- RecruitingPHASE1, PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
This study looks at a medicine called regadenoson in children, from babies to teenagers. It checks how safe it is and how it works in their bodies during a heart scan to help doctors understand heart conditions better.
For: Myocardial Ischemia · Coronary Artery DiseaseFrance · Greece · Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
A 26-Week (with 26 Week Extension) Randomized, Multi-Center, Double-Blind Phase 2 Study to Evaluate the Efficacy and Safety of XC001 Gene Therapy as an Adjunct to Coronary Artery Bypass Graft Surgery for Patients with Symptomatic Coronary Artery Disease with Left Ventricular Dysfunction at Risk for Incomplete Revascularization
This study looks into a new gene therapy, XC001, for people with severe heart disease who've had bypass surgery. It aims to see if XC001 can help improve heart function and reduce chest pain more than a dummy treatment.
For: Chronic angina and left ventricular dysfunction due to coronary artery disease that is considered high risk for incomplete revascularization via coronary artery bypass graftingNetherlands · Germany · Hungary